{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~19 mi. (Baton Rouge, Louisiana, +523 more cities)
facility
Ochsner High Grove
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)
city
~19 mi. (Baton Rouge, Louisiana, +147 more cities)
facility
Our Lady of the Lake Regional Medical Center. ( Site 0031)
condition
Cervical Adenocarcinoma, +2 more conditions
drug
brachytherapy, +3 more drugs
drug type
chemotherapy, +2 more types
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.
city
~19 mi. (Baton Rouge, Louisiana, +230 more cities)
facility
Research Site
biomarker
ER Positive, +1 more biomarker
drug
camizestrant, +3 more drugs
drug type
hormone therapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~19 mi. (Baton Rouge, Louisiana, +825 more cities)
facility
Our Lady of the Lake Physicians Group - Medical Oncology, +8 more facilities
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
city
~19 mi. (Baton Rouge, Louisiana, +102 more cities)
facility
Hematology Oncology Clinic
drug
abiraterone, +2 more drugs
drug type
hormone therapy, +1 more type
S0820, Adenoma and Second Primary Prevention Trial
city
~19 mi. (Baton Rouge, Louisiana, +616 more cities)
facility
Ochsner Health Center-Summa, +2 more facilities
condition
Colon Carcinoma, +1 more condition
drug
eflornithine, +2 more drugs
drug type
chemotherapy, +1 more type